mir-20221003

0001628280-22-025820.txt : 20221003 0001628280-22-025820.hdr.sgml : 20221003 20221003085300 ACCESSION NUMBER: 0001628280-22-025820 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20221003 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20221003 DATE AS OF CHANGE: 20221003 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mirion Technologies, Inc. CENTRAL INDEX KEY: 0001809987 STANDARD INDUSTRIAL CLASSIFICATION: MEASURING & CONTROLLING DEVICES, NEC [3829] IRS NUMBER: 830974996 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39352 FILM NUMBER: 221286131 BUSINESS ADDRESS: STREET 1: 1218 MENLO DRIVE CITY: ATLANTA STATE: GA ZIP: 30318 BUSINESS PHONE: (770) 432-2744 MAIL ADDRESS: STREET 1: 1218 MENLO DRIVE CITY: ATLANTA STATE: GA ZIP: 30318 FORMER COMPANY: FORMER CONFORMED NAME: GS Acquisition Holdings Corp II DATE OF NAME CHANGE: 20200417 8-K 1 mir-20221003.htm 8-K mir-20221003

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (date of earliest event reported): October 3, 2022

Mirion Technologies, Inc.

(Exact Name of Registrant as Specified in Its Charter)


Delaware	001-39352	83-0974996
(State or Incorporation)	(Commission File Number)	(I.R.S. Employer Identification Number)

	1218 Menlo Drive
	Atlanta, Georgia 30318
	(Address of Principal Executive Offices)

	(770) 432-2744
	(Registrant's telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange
on which registered

Class A common stock, $0.0001 par value per share

MIR

New York Stock Exchange

Redeemable warrants to purchase Class A common stock

MIR WS

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 3, 2022, Mirion Technologies, Inc. (the “Company”) announced the appointment of Michael Rossi, as Medical Group President of the Company.

Prior to joining the Company, Mr. Rossi, age 51, was the Head of Radioligand Imaging for the Advanced Accelerator Applications business of Novartis. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing levels of responsibility. Michael also brings experience from GE Healthcare, Tyco Healthcare/Mallinckrodt and Syncor International to the Mirion team. Michael earned a Bachelor of Science in Pharmacy degree from the University of the Sciences – Philadelphia College of Pharmacy and carries the Authorized Nuclear Pharmacist Certification from Butler University. Michael has also served on several Boards of Directors and remains a Licensed Pharmacist in the state of Pennsylvania.

In connection with Mr. Rossi’s appointment, the Company entered into an employment agreement with Mr. Rossi. The employment agreement provides for, among other things: (i) an annual base salary of $470,000, (ii) an annual target bonus of 60% of base salary (with such target subject to increase up to a maximum of 120% of base salary or decrease up to a minimum of 30% of base salary, as determined by the Company’s board of directors (the “Board”) or a committee thereof) based upon the achievement of certain performance and individual metrics, (iii) an initial award of restricted stock units (“RSUs”) under the Company’s Omnibus Incentive Plan (the “Plan”) valued at approximately $650,000 and (iv) eligibility to participate in the Company’s health and welfare benefit plans and the Company’s deferred compensation plan. The employment agreement also provides that Mr. Rossi will be eligible for additional equity awards under the Plan with a grant date fair value of no less than 106% of Mr. Rossi’s then current base salary (“LTI awards”), which LTI awards are expected to be made on an annual basis on or around April 1 of each calendar year.

In addition, the employment agreement provides that upon the termination of Mr. Rossi’s employment with the Company without “cause” or by Mr. Rossi for “good reason,” (each as defined in the employment agreement), then subject to his execution and non-revocation of a general release of claims against the Company, Mr. Rossi will be entitled, in addition to any accrued amounts, to (i) continuation of his annual base salary for twelve (12) months following the termination date of his employment (provided that, if Mr. Rossi’s employment is terminated without cause or for good reason within twelve (12) months of a “change in control” (as such term is defined in the Plan), Mr. Rossi will receive an amount equal to one (1) times the sum of his base salary and target bonus), (ii) a pro-rata portion of Mr. Rossi’s annual incentive bonus for the fiscal year in which the termination of his employment occurs and (iii) continued payment by the Company, for the twelve (12) months following the termination date of his employment, of the group health continuation coverage premiums for Mr. Rossi and his dependents under COBRA. The employment agreement also provides that in the event of Mr. Rossi’s death or permanent disability, Mr. Rossi or his estate will be entitled, in addition to any accrued amounts, to a pro-rata annual incentive bonus.

There are no arrangements or understandings between Mr. Rossi and any other persons pursuant to which Mr. Rossi was appointed as the Group President, Medical of the Company and there are no family relationships between Mr. Rossi and any director or executive officer of the Company. Additionally, there are no transactions between Mr. Rossi and the Company or its subsidiaries that would be required to be reported under Item 404(a) of Regulation S-K.

Item 7.01. Regulation FD Disclosure.

On October 3, 2022, the Company issued a press release regarding the appointment of Mr. Rossi as Group President, Medical. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information contained in this Item 7.01 and Exhibit 99.1 attached hereto is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

EXHIBIT INDEX


Exhibit Number						Description
99.1*						Mirion Technologies, Inc. press release dated October 3, 2022
104						Exhibit 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

* Filed herewith.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: October 3, 2022

Mirion Technologies, Inc.


By:			/s/ Brian Schopfer
Name:			Brian Schopfer
Title:			Chief Financial Officer

EX-99.1 2 a2022-10x03pressrelease.htm EX-99.1 Document



News Release

Mirion Technologies Appoints Michael Rossi as President of Mirion Medical

Atlanta, GA – October 3, 2022 – Mirion Technologies, Inc. (“Mirion,” “we” or the “Company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced the appointment of Michael Rossi as the President of Mirion Medical. Michael will report directly to Mirion’s CEO, Tom Logan, who had been acting as President of the business segment.

Michael joins Mirion from Novartis, where he most recently served as the Head of Radioligand Imaging for the Advanced Accelerator Applications business. Prior to Novartis, Michael spent five years at Jubilant Pharma where he served in several different roles with increasing levels of responsibility. Michael also brings experience from GE Healthcare, Tyco Healthcare/Mallinckrodt and Syncor International to the Mirion team. Michael earned a Bachelor of Science in Pharmacy degree from the University of the Sciences – Philadelphia College of Pharmacy and carries the Authorized Nuclear Pharmacist Certification from Butler University. Michael has also served on several Boards of Directors and remains a Licensed Pharmacist in the state of Pennsylvania.

“I am thrilled to welcome Michael to the Mirion team,” said Tom Logan, Mirion’s CEO. “Michael has a unique blend of domain experience and leadership qualities in the nuclear medicine space. His appointment comes at an exciting time for the Company, as we aim to drive organic and inorganic growth and margin expansion across our medical business. I am confident that Michael will accelerate the attainment of our healthcare ambitions.”

“I am incredibly excited to be joining Mirion Medical at such an impactful time in the Company’s growth trajectory,” added Michael Rossi. “What Tom and the team have built over the last few years is truly impressive and I look forward to building off the solid momentum with my new colleagues.”

About Mirion

Mirion Technologies is a leading provider of detection, measurement, analysis and monitoring solutions to the nuclear, defense, medical and research end markets. The organization aims to harness its unrivaled knowledge of ionizing radiation for the greater good of humanity. Headquartered in Atlanta (GA – USA), Mirion employs around 2,800 people and operates in 13 countries. For more information, and for the latest news and content from Mirion, visit ir.mirion.com.

Contacts:

For investor inquiries:

Jerry Estes

ir@mirion.com

For media inquiries:

Matthew Maddox

mmaddox@mirion.com

EX-101.SCH 3 mir-20221003.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 mir-20221003_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 mir-20221003_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Central Index Key Entity Central Index Key Entity Address, Address Line One Entity Address, Address Line One Trading Symbol Trading Symbol Entity File Number Entity File Number Soliciting Material Soliciting Material Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Warrant Warrant [Member] Class of Stock [Domain] Class of Stock [Domain] City Area Code City Area Code Entities [Table] Entities [Table] Title of 12(b) Security Title of 12(b) Security Amendment Flag Amendment Flag Entity Information [Line Items] Entity Information [Line Items] Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Document Period End Date Document Period End Date Entity Tax Identification Number Entity Tax Identification Number Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, City or Town Entity Address, City or Town Class of Stock [Axis] Class of Stock [Axis] Local Phone Number Local Phone Number Common Class A Common Class A [Member] Written Communications Written Communications Cover [Abstract] Document Type Document Type Entity Emerging Growth Company Entity Emerging Growth Company Entity Address, State or Province Entity Address, State or Province Pre-commencement Tender Offer Pre-commencement Tender Offer EX-101.PRE 6 mir-20221003_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 mirion.jpg GRAPHIC begin 644 mirion.jpg MB5!.1PT*&@H -24A$4@ 2, !2" 8 ?*;+] 7-21T( KLX< MZ0 1G04U! "QCPO\804 )<$A9

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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2

Cover

Oct. 03, 2022

Entity Information [Line Items]

Document Type 8-K

Document Period End Date Oct. 03, 2022

Entity Registrant Name Mirion Technologies, Inc.

Entity Incorporation, State or Country Code DE

Entity File Number 001-39352

Entity Tax Identification Number 83-0974996

Entity Address, Address Line One 1218 Menlo Drive

Entity Address, City or Town Atlanta

Entity Address, State or Province GA

Entity Address, Postal Zip Code 30318

City Area Code 770

Local Phone Number 432-2744

Written Communications false

Soliciting Material false

Pre-commencement Tender Offer false

Pre-commencement Issuer Tender Offer false

Entity Emerging Growth Company false

Amendment Flag false

Entity Central Index Key 0001809987

Common Class A

Entity Information [Line Items]

Title of 12(b) Security Class A common stock, $0.0001 par value per share

Trading Symbol MIR

Security Exchange Name NYSE

Warrant

Entity Information [Line Items]

Title of 12(b) Security Redeemable warrants to purchase Class A common stock

Trading Symbol MIR WS

Security Exchange Name NYSE

Cover	Oct. 03, 2022
Entity Information [Line Items]
Document Type	8-K
Document Period End Date	Oct. 03, 2022
Entity Registrant Name	Mirion Technologies, Inc.
Entity Incorporation, State or Country Code	DE
Entity File Number	001-39352
Entity Tax Identification Number	83-0974996
Entity Address, Address Line One	1218 Menlo Drive
Entity Address, City or Town	Atlanta
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30318
City Area Code	770
Local Phone Number	432-2744
Written Communications	false
Soliciting Material	false
Pre-commencement Tender Offer	false
Pre-commencement Issuer Tender Offer	false
Entity Emerging Growth Company	false
Amendment Flag	false
Entity Central Index Key	0001809987
Common Class A
Entity Information [Line Items]
Title of 12(b) Security	Class A common stock, $0.0001 par value per share
Trading Symbol	MIR
Security Exchange Name	NYSE
Warrant
Entity Information [Line Items]
Title of 12(b) Security	Redeemable warrants to purchase Class A common stock
Trading Symbol	MIR WS
Security Exchange Name	NYSE

XML 9 mir-20221003_htm.xml IDEA: XBRL DOCUMENT 0001809987 2022-10-03 2022-10-03 0001809987 us-gaap:CommonClassAMember 2022-10-03 2022-10-03 0001809987 us-gaap:WarrantMember 2022-10-03 2022-10-03 false 0001809987 8-K 2022-10-03 Mirion Technologies, Inc. DE 001-39352 83-0974996 1218 Menlo Drive Atlanta GA 30318 770 432-2744 false false false false Class A common stock, $0.0001 par value per share MIR NYSE Redeemable warrants to purchase Class A common stock MIR WS NYSE false EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( )U&0U4'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " "=1D-5O7O@P.X K @ $0 &1O8U!R;W!S+V-O&ULS9+! M2L0P$(9?17)O)VU9#Z';B^))07!!\18FL[O!I@G)2+MO;UIWNX@^@)!+9OY\ M\PVDQ:#01WJ./E!D2^EF&W-S[Z#3G:SQ T/BA M#P2UE+?@B+71K&$&%F$EBJXUJ#"29A_/>(,K/GS&?H$9!.K)T< )JK("T'MZ?%G6+>R0 M6 ](^56RBD^!MN(R^;6YN]\]B*Z6=5U4LI#-KJK5)I_-^^SZP^\J[+RQ>_N/ MC2^"70N__D7W!5!+ P04 " "=1D-5F5R<(Q & "<)P $P 'AL+W1H M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X M8-DOV]:[MR_>X%#BVR]*+ M41B1%G\@M MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7 MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V< M/!T3$LV4"P9!AI@S M&L%&KQMUAVC2/'K^!?F<-0HACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0' MHYI9";V$5FJ?JH,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RSTS0LS0[=R2^JVE+ZU)CA* M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D* MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-# MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P MOFH]M!5.S_Y9KF4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2 MD 83 >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+ M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5 M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0 ( M )U&0U5E+OH$SP0 !,5 8 >&PO=V]R:W-H965T&UL MM9AA;^)&$(;_RLJMJE9*@KTF 5) (B2YHKLD*-!&;=4/B[W *K;7M[L.X=]W MUB8VU9DQB:Y?@@V>-X]W9MY9N[^1ZEFO.3?D-8X2/7#6QJ27K98.UCQF^DRF M/(%?EE+%S,"I6K5TJC@+\Z X:E'7O6C%3"3.L)]_-U7#OLQ,)!(^541G<Q6AO[16O83]F*S[CY/9TJ.&N5*J&(>:*%3(CBRX$S\BZO M_#P@O^(/P3=Z[YC86UE(^6Q/)N' <2T1CWA@K 2#CQ<^YE%DE8#CZT[4*?^G M#=P_?E._S6\>;F;!-!_+Z$F$9CUPN@X)^9)ED7F4F]_X[H;.K5X@(YW_)9OB MVG;;(4&FC8QWP4 0BZ3X9*^[A=@+./ H,2@)0;-]?P#>C>)$69+)DE19S9??W^!:\C$\%C_4P=8"+;K!6TQ M7^J4!7S@0+5JKEZX,_SI!^_"_17!]4M<'U,?7LL@@](T9+Y->1T<'MX]_8Q MM$N(]G$04ZZ$#,E-$A*H@5H>7"G/9I[.IGR>EVSGJ.(NGX]\);11#"#O65Q+ MANO<"65K8'$,(ZA)E4J55]T)F1E80B(5&+T2KW<,WB@,H>.A3G8')#>2AZ0V MB[BB1[TNN>-)),FU@NF!0'INY;CNNS#']@P*;BXW2:T3XW(C$T%_,0QM;QAX M[T(KFV&JY(M(@MHE;-#\-,+0J@'AH8;^#=I4:L,B\I=(#W9H@Z+O^EX78ZNF M@8?[>9[!$6R*#J/@ IV.BX%4$\'#C?R+#&!-IFN98(;1(-+VZ2GMM-L8434' M/-S GY0PAB>P,'&<)3N[T+54N-"211KMO\KV/=R:9S(2@3 B69$[*&\E6%3+ M@ZLT\E0F[^$./57\-(#EX=!?Q::")R%7Y&&Y/) _7*^1K+)[#W?G;\@F6F= MU@B(RS8"5H;O'>7X-S%7*YO/3Z!@UK;84I9L:]%PP28T6KD\;;!E6+ P7[3; MB*UJ-["X0"-*Y>KT*%YA \E[)9UZ[/@U2+FPGNFZOU^U@9'N[?MR" MK2O [F$<,1C3HUJ>_V.;3RMGI_YW?RY!K?ZCQ-4(H+A[SX6!W:)<$H_^O/B% MS'B0@077YQI7VF6%!$62X%$T>#XA/[IGM@A(RA1Y85'&20I6H-=,H<5:#0R* M^_Q,9!J3-"&,;%;.7+S&JQ9LN(''V$:A.[_G&$/ M [0:%!0W]B>F[*-4+0(:^=&BJP8%[7[W-D%GQ$>)J\E!<:-_3YO@2H\\Y#QF M"Y#;% G2Q$B29@K*1G-2UT;8*XAJPOCX@&CNE 8!Z!3R-,-8JA'CXW/A^&9I M$#K4+*V]5USV=>$=LQ-?DX@O0<<]ZX IJ.(-7'%B9)J_]5I(8V2<'ZXY@VV+ MO0!^7TIIWD[LB[3R/>CP7U!+ P04 " "=1D-5GZ ;\+$" #B# #0 M 'AL+W-T>6QEO%DN7/ZZZ>S;"=I=67=A['-HN6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZF MTVY#;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,7 M8&F? KP(&K XU7=>&18/ MQA<0&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B< M45XH!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^, M%F)?A+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL> M]O[+"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PEY7>>9 ]IV03NA1.XJR MY/K%.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD\%G'!QR>(W?#$T%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/ MAG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+ MV.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0 MIA@"IQ%', ; 4/2='@//GL?)=-[*CG_5U/\!%!+ P04 " "=1D-5EXJ[ M', 3 @ "P %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6 M!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV M)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(= MI7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( M )U&0U6JQ"(6,P$ "(" / >&PO=V]R:V)O;VLN>&ULC5'1;L(P#/R5 M*A^P%K0A#5%>0-N0I@V-B??0NM0BB2O'A8VOG]NJ&M)>]I31=B;FJ19IZFL:C!VWA'#02=5,3>BD(^IK%AL&6L <2[=)IEL]1;#&:Y M&+6VG-X"$B@$*2C9$7N$2_R==S Y8\0#.I3OW/1W!R;Q&-#C% MB/%*0:S;%4S.Y68R#/; @L4?>M>9_+2'V#-B#Q]6C>1FEJE@A1REW^CUK7H\ M@RX/J!5Z0B? :ROPS-0V&(Z=C*9(;V+T/8SG4.*<_U,C5146L*:B]1!DZ)'! M=09#K+&))@G60VY6= ;N\N@#FW+()FKJIBF>HPYX4P[V1D\E5!B@?%.9J+SV M4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04 " "=1D-5)!Z; MHJT #X 0 &@ 'AL+U]R96QS+W=O[IFB MG#S^0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6 M<%H@XLD@;6E6?;!/3K3G>1,)KM\,<'AT_@%02P,$% @ G49# M5660>9(9 0 SP, !, !;0V]N=&5N=%]4>7!E&ULK9--3L,P$(6O M$F5;)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1 ML.B=]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3K MU3.T.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY8 M4(JKA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F," MJ;$#(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R M]>S[04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]> M?P%02P$"% ,4 " "=1D-5!T%-8H$ "Q $ @ $ M 9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0 ( )U&0U6]>^# [@ "L" M 1 " :\ !D;V-0&UL4$L! A0#% @ G49#564N^@3/! $Q4 !@ M ("!#0@ 'AL+W=O7!E&UL4$L%!@ ) - D /@( &84 $! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 3 22 1 false 2 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.mirion.com/role/Cover Cover Cover 1 false false All Reports Book All Reports mir-20221003.htm a2022-10x03pressrelease.htm mir-20221003.xsd mir-20221003_def.xml mir-20221003_lab.xml mir-20221003_pre.xml http://xbrl.sec.gov/dei/2022 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "mir-20221003.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 3, "dts": { "definitionLink": { "local": [ "mir-20221003_def.xml" ] }, "inline": { "local": [ "mir-20221003.htm" ] }, "labelLink": { "local": [ "mir-20221003_lab.xml" ] }, "presentationLink": { "local": [ "mir-20221003_pre.xml" ] }, "schema": { "local": [ "mir-20221003.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 29, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 22, "memberCustom": 0, "memberStandard": 2, "nsprefix": "mir", "nsuri": "http://www.mirion.com/20221003", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mir-20221003.htm", "contextRef": "ibd20e2c86fc9409eb9836f8ba2e19d3c_D20221003-20221003", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.mirion.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "mir-20221003.htm", "contextRef": "ibd20e2c86fc9409eb9836f8ba2e19d3c_D20221003-20221003", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 2, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntitiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to assemble all relevant information about each entity associated with the document instance", "label": "Entities [Table]", "terseLabel": "Entities [Table]" } } }, "localname": "EntitiesTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Entity Information [Line Items]", "terseLabel": "Entity Information [Line Items]" } } }, "localname": "EntityInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Class A [Member]", "terseLabel": "Common Class A" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "domainItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "stringItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrant [Member]", "terseLabel": "Warrant" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.mirion.com/role/Cover" ], "xbrltype": "domainItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 16 0001628280-22-025820-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-22-025820-xbrl.zip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